No Data
No Data
Fractyl Health Management to Meet Virtually With B. Riley
Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript Summary
BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating
Fractyl Health's Strategic Advancements and Promising Data Drive Buy Rating
Morgan Stanley Maintains Fractyl Health(GUTS.US) With Buy Rating, Maintains Target Price $18
Fractyl Health Reports Q3 2024 Financial Performance
No Data
No Data